China Sxt Pharmaceuticals Share Price Today
(NASDAQ: SXTC)

Name: China Sxt Pharmaceuticals Share Price Today (NASDAQ: SXTC) - China Sxt Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

China Sxt Pharmaceuticals share price is $5.01 & ₹436.20 as on 6 Mar 2025, 2.30 'hrs' IST

$5.01

▲

0.31

(6.72%)

Market is closed - opens 8 PM, 06 Mar 2025

View live China Sxt Pharmaceuticals share price in Dollar and Rupees. Guide to invest in China Sxt Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in China Sxt Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

China Sxt Pharmaceuticals share price movements

Today's Low: $4.61
Today's High: $5.15
$5.01
7.98%
Downside
Day's Volatility :10.48%
Upside
2.72%
52 Weeks Low: $2.40
52 Weeks High: $26.96
$5.01
52.1%
Downside
52 Weeks Volatility :91.1%
Upside
81.42%

China Sxt Pharmaceuticals (SXTC) Returns

Period	China Sxt Pharmaceuticals Inc	Index (Russel 2000)
3 Months	71.4%	0.0%
6 Months	6.42%	0.0%
1 Year	-68.4%	0.0%
3 Years	-99.29%	-11.6%

China Sxt Pharmaceuticals (SXTC) Key Statistics

in dollars & INR

Previous Close	$4.69
Open	$4.675
Today's High	$5.15
Today's Low	$4.6101
Market Capitalization	$2.4M
Today's Volume	$41.0K
52 Week High	$26.96
52 Week Low	$2.4
Revenue TTM	$1.9M
EBITDA	$-1.9M
Earnings Per Share (EPS)	$-29.78
Profit Margin	-160.67%
Quarterly Earnings Growth YOY	0.43%
Return On Equity TTM	-21.65%

How to invest in China Sxt Pharmaceuticals Stock (SXTC) from India?

It is very easy for Indian residents to invest directly in China Sxt Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the China Sxt Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for China Sxt Pharmaceuticals or SXTC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of China Sxt Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of China Sxt Pharmaceuticals shares which would translate to 0.174 fractional shares of China Sxt Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like China Sxt Pharmaceuticals, in just a few clicks!

Returns in China Sxt Pharmaceuticals (SXTC) for Indian investors in Rupees

The China Sxt Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

China Sxt Pharmaceuticals investment value today

Current value as on today

₹36,693

Returns

₹63,307

(-63.31%)

Returns from China Sxt Pharmaceuticals Stock

₹68,371 (-68.37%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards China Sxt Pharmaceuticals (SXTC)

67%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for China Sxt Pharmaceuticals Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in China Sxt Pharmaceuticals

Bank of Montreal
0.25%
BMO Capital Markets Corp.
0.25%

Analyst Recommendation on China Sxt Pharmaceuticals

Insights on China Sxt Pharmaceuticals Stock (Ticker Symbol: SXTC)

Price Movement
In the last 1 month, SXTC stock has moved up by 57.7%
Decreasing Revenue
Revenue is down for the last 3 quarters, 939.58K → 494.45K (in $), with an average decrease of 23.7% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -9.69M → 3.29M (in $), with an average increase of 197.0% per quarter
SXTC vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 98.7% return, outperforming this stock by 167.1%
SXTC vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.1% return, outperforming this stock by 237.4%
Price to Sales
ForSXTC every $1 of sales, investors are willing to pay $0.3, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

SXTC China Sxt Pharmaceuticals Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$7.0M	↓ 0.1%
Net Income	$1.5M	↑ 29.61%
Net Profit Margin	21.95%	↑ 5.03%

	FY20	Y/Y Change
Revenue	$5.2M	↓ 26.38%
Net Income	$-10.3M	↓ 768.38%
Net Profit Margin	-199.29%	↓ 221.24%

	FY21	Y/Y Change
Revenue	$4.8M	↓ 7.45%
Net Income	$-2.7M	↓ 73.29%
Net Profit Margin	-57.52%	↑ 141.77%

	FY22	Y/Y Change
Revenue	$2.6M	↓ 45.53%
Net Income	$-5.7M	↑ 108.72%
Net Profit Margin	-220.43%	↓ 162.91%

	FY23	Y/Y Change
Revenue	$2.0M	↓ 24.23%
Net Income	$-5.9M	↑ 3.46%
Net Profit Margin	-301.0%	↓ 80.57%

	FY24	Y/Y Change
Revenue	$1.9M	↓ 2.19%
Net Income	$-3.1M	↓ 47.79%
Net Profit Margin	-160.67%	↑ 140.33%

	Q3 FY22	Q/Q Change
Revenue	$1.2M	↓ 110.5%
Net Income	$-1.5M	↓ 164.37%
Net Profit Margin	-123.7%	↓ 103.51%

	Q4 FY22	Q/Q Change
Revenue	$381.7K	↓ 68.41%
Net Income	$-2.2M	↑ 48.54%
Net Profit Margin	-581.64%	↓ 457.94%

	Q2 FY23	Q/Q Change
Revenue	$469.8K	↑ 23.08%
Net Income	$-4.8M	↑ 118.37%
Net Profit Margin	-1.0K%	↓ 450.32%

	Q3 FY23	Q/Q Change
Revenue	$939.6K	↑ 100.0%
Net Income	$-9.7M	↑ 100.0%
Net Profit Margin	-1.0K%	↑ 0.0%

	Q4 FY23	Q/Q Change
Revenue	$494.5K	↓ 47.37%
Net Income	$3.3M	↓ 134.02%
Net Profit Margin	667.16%	↑ 1699.12%

	Q2 FY24	Q/Q Change
Revenue	$494.5K	↑ 0.0%
Net Income	$3.3M	↑ 0.0%
Net Profit Margin	667.16%	↑ 0.0%

	FY19	Y/Y Change
Profit	$4.6M	↑ 35.57%

	FY20	Y/Y Change
Profit	$2.7M	↓ 41.37%

	FY21	Y/Y Change
Profit	$2.8M	↑ 5.02%

	FY22	Y/Y Change
Profit	$1.3M	↓ 55.92%

	FY23	Y/Y Change
Profit	$426.3K	↓ 65.94%

	FY24	Y/Y Change
Profit	$554.0K	↑ 29.96%

	Q3 FY22	Q/Q Change
Profit	$89.7K	↓ 100.58%

	Q4 FY22	Q/Q Change
Profit	$168.3K	↑ 87.65%

	Q2 FY23	Q/Q Change
Profit	$144.2K	↓ 14.33%

	Q3 FY23	Q/Q Change
Profit	$185.6K	↑ 28.73%

	Q4 FY23	Q/Q Change
Profit	$132.8K	↓ 28.44%

	Q2 FY24	Q/Q Change
Profit	$132.8K	↑ 0.0%

	FY19	Y/Y Change
Operating Cash Flow	$239.2K	↓ 87.54%
Investing Cash Flow	$-610.1K	↓ 41.94%
Financing Cash Flow	$9.0M	↓ 2977.66%

	FY20	Y/Y Change
Operating Cash Flow	$934.2K	↑ 290.58%
Investing Cash Flow	$-5.5M	↑ 800.97%
Financing Cash Flow	$3.0M	↓ 66.55%

	FY21	Y/Y Change
Operating Cash Flow	$-1.3M	↓ 240.92%
Investing Cash Flow	$-5.8M	↑ 5.62%
Financing Cash Flow	$12.4M	↑ 310.32%

	FY22	Y/Y Change
Operating Cash Flow	$268.3K	↓ 120.38%
Investing Cash Flow	$-46.9K	↓ 99.19%
Financing Cash Flow	$1.6M	↓ 87.15%

	Q3 FY22	Q/Q Change
Operating Cash Flow	$-549.1K	↓ 88.62%
Investing Cash Flow	$19.7K	↑ 0.0%
Financing Cash Flow	$-11.1M	↓ 306.86%

China Sxt Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

China Sxt Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

China Sxt Pharmaceuticals (SXTC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
China Sxt Pharmaceuticals Inc	56.8%	6.42%	-68.4%	-99.29%	-99.97%
Zoetis Inc.	-3.04%	-10.5%	-9.01%	-11.21%	28.74%
Intra-cellular Therapies, Inc.	3.38%	81.15%	98.68%	146.46%	588.66%
Haleon Plc Spon Ads	10.71%	2.13%	26.53%	42.24%	42.24%
Neurocrine Biosciences Inc.	-25.31%	-6.07%	-13.91%	29.45%	28.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
China Sxt Pharmaceuticals Inc	NA	NA	NA	0.0	-0.22	-0.05	NA	50.24
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.35	26.35	1.92	0.36	0.09	0.04	0.02	1.8
Neurocrine Biosciences Inc.	34.6	34.6	0.27	6.44	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
China Sxt Pharmaceuticals Inc	NA	$2.4M	-99.97%	NA	-160.67%
Zoetis Inc.	Buy	$76.1B	28.74%	31.17	26.86%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.66%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$47.7B	42.24%	26.35	12.84%
Neurocrine Biosciences Inc.	Buy	$11.4B	28.72%	34.6	14.49%

About China Sxt Pharmaceuticals

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Organization	China Sxt Pharmaceuticals
Employees	75
CEO	Mr. Feng Zhou
Industry	Health Technology

Management People of China Sxt Pharmaceuticals

Name	Title
Mr. Feng Zhou	Chairman of the Board & Co-CEO
Mr. Xiaodong Pan	Chief Financial Officer
Mr. Jun Zheng	Executive Director
Mr. Sze Beng Lim	Co-Chief Executive Officer

Important FAQs about investing in SXTC Stock from India :

What is China Sxt Pharmaceuticals share price today?

China Sxt Pharmaceuticals share price today stands at $5.01, Open: $4.68 ; Previous Close: $4.69 ; High: $5.15 ; Low: $4.61 ; 52 Week High: $26.96 ; 52 Week Low: $2.40.

The stock opens at $4.68, after a previous close of $4.69. The stock reached a daily high of $5.15 and a low of $4.61, with a 52-week high of $26.96 and a 52-week low of $2.40.

Can Indians buy China Sxt Pharmaceuticals shares?

Yes, Indians can invest in the China Sxt Pharmaceuticals (SXTC) from India.

With INDmoney, you can buy China Sxt Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy China Sxt Pharmaceuticals at zero transaction cost.

How can I buy China Sxt Pharmaceuticals shares from India?

It is very easy to buy China Sxt Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of China Sxt Pharmaceuticals (SXTC) be purchased?

Yes, you can buy fractional shares of China Sxt Pharmaceuticals with INDmoney app.

What are the documents required to start investing in China Sxt Pharmaceuticals stocks?

To start investing in China Sxt Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.